KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$18.9 million.

  • Emergent BioSolutions' Non Operating Income fell 12426.19% to -$18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 20916.03%. This contributed to the annual value of -$34.2 million for FY2024, which is 48426.97% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Non Operating Income is -$18.9 million, which was down 12426.19% from -$18.4 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Non Operating Income ranged from a high of $77.9 million in Q3 2024 and a low of -$66.3 million during Q2 2024
  • Moreover, its 5-year median value for Non Operating Income was -$10.8 million (2021), whereas its average is -$4.2 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 49537.04% in 2023, then plummeted by 70333.33% in 2024.
  • Emergent BioSolutions' Non Operating Income (Quarter) stood at -$9.9 million in 2021, then soared by 38.38% to -$6.1 million in 2022, then skyrocketed by 149.18% to $3.0 million in 2023, then plummeted by 703.33% to -$18.1 million in 2024, then dropped by 4.42% to -$18.9 million in 2025.
  • Its last three reported values are -$18.9 million in Q3 2025, -$18.4 million for Q2 2025, and $69.7 million during Q1 2025.